O
ORIC Pharmaceuticals, Inc. (ORIC)
NMS – Real Time Price. Currency in USD
9.53
+0.07 (0.74%)
At close: Jun 26, 2026, 4:00 PM EDT
9.47
-0.06 (-0.63%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
9.53
+0.07 (0.74%)
At close: Jun 26, 2026, 4:00 PM EDT
9.47
-0.06 (-0.63%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $56.4M significantly exceed its total debt $3.3M, ensuring strong financial flexibility
Total current assets $290.2M exceed Total current liabilities $17.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$33.4M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 16.33 | 6.05 | 10 | |
| Quick ratio | 16.33 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -966K | -1M | -1M | -1M | -1M |
| Operating Income | -87M | -111M | -143M | -143M | -150M |
| Net Income | -89M | -101M | -128M | -129M | -135M |
| EBITDA | -86M | -110M | -142M | -142M | -149M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 23.5 | 5.5 |
| Next quarter | N/A | -12.6 | 1.0 |
| Current year | N/A | 0.47 | 1.5 |
| Next year | N/A | -8.73 | 1.0 |
| Weighted average score | 2.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -17.24 | -13.32 | -47.21 | 3.3 |
| Y/Y | 999 | -19.13 | 19.05 | -0.81 | 5.3 |
| 3y average | 999 | -13.72 | 13.06 | -14.39 | 5.0 |
| 5y average | 999 | -12.23 | 13.78 | -20.67 | 5.0 |
| Weighted average score | 4.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |